Vogenx, Inc. (VOGX)
NASDAQ: VOGX · Real-Time Price · USD
30.62
+0.76 (2.55%)
At close: Sep 11, 2026, 4:00 PM EDT
32.71
+2.09 (6.83%)
After-hours: Sep 11, 2026, 4:10 PM EDT
Vogenx Market Cap
Vogenx has a market cap or net worth of $426.16 million as of September 11, 2026.
Market Cap
426.16M
Enterprise Value
426.74M
1-Year Change
n/a
Ranking
Category
Stock Price
$30.62
ChartMarket Cap Chart
Since the IPO on August 12, 2026, Vogenx's market cap has increased from $180.77M to $426.16M, an increase of 135.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 426.16M | 2.55% |
| Sep 10, 2026 | 415.58M | 0.20% |
| Sep 9, 2026 | 414.74M | -6.88% |
| Sep 8, 2026 | 445.36M | 0.85% |
| Sep 4, 2026 | 441.61M | -1.31% |
| Sep 3, 2026 | 447.45M | 0.16% |
| Sep 2, 2026 | 446.75M | -3.11% |
| Sep 1, 2026 | 461.09M | -2.56% |
| Aug 31, 2026 | 473.20M | 0.12% |
| Aug 28, 2026 | 472.64M | 0.98% |
| Aug 27, 2026 | 468.05M | 2.28% |
| Aug 26, 2026 | 457.61M | 4.28% |
| Aug 25, 2026 | 438.82M | 2.60% |
| Aug 24, 2026 | 427.69M | 4.10% |
| Aug 21, 2026 | 410.85M | 24.82% |
| Aug 20, 2026 | 329.15M | 2.12% |
| Aug 19, 2026 | 322.33M | 17.27% |
| Aug 18, 2026 | 274.87M | 25.40% |
| Aug 17, 2026 | 219.20M | 6.56% |
| Aug 14, 2026 | 205.70M | 4.90% |
| Aug 13, 2026 | 196.10M | 8.48% |
| Aug 12, 2026 | 180.77M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inhibikase Therapeutics | 424.23M |
| Benitec Biopharma | 419.81M |
| C4 Therapeutics | 418.29M |
| Atea Pharmaceuticals | 415.46M |
| Editas Medicine | 406.99M |
| Larimar Therapeutics | 401.87M |
| Turn Therapeutics | 398.56M |
| Arcturus Therapeutics Holdings | 397.35M |